X

On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business. Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled. Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests. If you have any questions related to this announcement, please contact your healthcare provider or your One to One Nurse at 1-855-557-2483.

MAT-US-2015317

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

SUPPORT PARTNER TIPS

Advice for people who care for someone with Relapsing MS

There are many different types of relapsing MS Support Partners—spouses to parents to friends. One thing they all have in common is that they make a real difference in the lives of those they care for, providing comfort and support.

In the list below, you’ll see some ways that a Support Partner can show they care. For someone with relapsing MS, even the simplest ideas can make a big difference.

Ways to provide invaluable support

  • You can help your loved one track symptoms to see if there are signs of new or worsening disease activity.
  • Be open and honest when discussing your loved one’s relapsing MS treatment goals.
  • Gathering information and weighing benefits and risks are activities many Support Partners help with.
  • Go to healthcare provider appointments together. Listening and taking notes may help you remember something from the appointment that your partner does not.
  • Reviewing this website with your loved one will help you both learn more about LEMTRADA, including important safety and results of clinical trials.
  • You and your loved one can use this information along with the downloadable Healthcare Provider Discussion Guide to talk to your doctor about LEMTRADA.

Catherine
LEMTRADA
PATIENT

He does
his best

To understand
What I’m
feeling.

Patients discuss the importance of having support partners.

Corey
SUPPORT
PARTNER

I had a role

In the
treatment
decision.

Corey discusses how he supported his wife during treatment.

Important Safety Information See More

LEMTRADA can cause serious side effects including serious autoimmune problems. Some people receiving LEMTRADA develop a condition where the immune cells in your body attack other cells or organs in the body (autoimmunity), which can be serious and may cause death. Serious autoimmune problems may include: